Authors


Austin Triplett, PharmD Candidate

Latest:

Surprising Drugs That Can Cause Serotonin Syndrome

Specific drugs, foods, and supplements can lead to this condition.


Ann Cella, MA, MEd, RN, NEA-BC

Latest:

Pharmacists, Nurses Improve Medication Communication, Patient Experience Through Development of Medication Safety Patient Education Program

Given the increasing value of patient satisfaction in determining the quality of care in the hospital reimbursement model, research is flourishing with a focus on identifying the factors that could positively influence patient satisfaction outcomes.


Michael Hair, 2024 PharmD Candidate

Latest:

Advise Patients About OTC Options for Treating Motion Sickness

Many cases of motion sickness can be managed safely with available OTC products.


Carmen Janes, PharmD, BCOP

Latest:

Milestones That Matter: Using Molecular and Clinical Benchmarks to Guide CML Therapy

An expert discusses how achieving molecular and clinical milestones early in chronic myeloid leukemia (CML) treatment reduces transformation risk, enables potential treatment discontinuation after specific criteria are met, and helps identify treatment resistance requiring mutational analysis or adherence assessment.


Bailey Scism, PharmD

Latest:

Is a 90-Day Supply the Best Option to Improve Medication Adherence?

Interventions to improve medication adherence may have a greater impact on individual patients and the population as a whole than any novel treatment or therapy.


Jawad Butt, MD

Latest:

FINEARTS-HF Analysis: How Liver Biomarkers Influence Heart Failure Risk

Jawad Butt, MD, offers insight into his analysis of the FINEARTS-HF trial.


Priyank Kumar, BPharm, MS, PhD

Latest:

Bridging the Gap: Industry-Academia Collaboration in Pharmacy

The most persuasive reason for industry-academia collaboration is the many opportunities it opens for pharmacy students who may not have considered all the ways they can use their PharmD to serve the cause of humankind.


Gillian Woollett, MA, DPhil

Latest:

Confusion Persists Around the Interchangeability Designation for Biosimilars

The legal and common uses of “interchangeability” continue to be conflated.


Thomas Lodise, PharmD, PhD

Latest:

Unmet Needs in Management of C. Difficile Infection (CDI)

Bincy Abraham, MD, MS; Thomas Lodise, PharmD, PhD; Teena Chopra, MD, MPH; and Paul Feuerstadt, MD, share unmet needs, including access to therapies, in treatment of C. difficile infection (CDI).


Melissa Martinez, PharmD Candidate

Latest:

Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic Population

Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.


Tiffany Gray, CPhT

Latest:

Half of Pharmacy Technicians Feel Fulfilled in Their Current Role

The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.


Shaziya Barkat, PharmD, CSP

Latest:

America Must Address the Pandemic of Health Care Inequities

Black History Month provides a reminder of the systemic barriers facing many Americans


Suneri Amin

Latest:

Case Studies: June 2022

How would you respond to these patients questions?


Dannoy Gibson

Latest:

Oncology Overview: Selpercatinib for RET-Positive Metastatic Non-Small Cell Lung Cancer

Selpercatinib is an oral selective RET kinase inhibitor approved for the treatment of metastatic RET fusion-positive non-small cell lung cancer and for metastatic thyroid cancer.


Lucas W. Morgan, Esq

Latest:

Developing Relationships With State Boards of Pharmacy Is Valuable for Pharmacies and Pharmacists

A pharmacy's relationship with its state board(s) of pharmacy is crucial for its operation and success, yet it is often overlooked due to the complex demands on pharmacists and pharmacy owners.



Rosa Lee, PharmD

Latest:

Transforming What Community Pharmacy Offers: Giant Food’s Cancer Screening Initiative

This screening method can help empower patients to better manage their health and seek additional care.


Lindsey Miller, PharmD Candidate

Latest:

Equal but Not the Same—2021 Update on Influenza Vaccines

As COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.


Ashley Woodyard, PharmD Candidate

Latest:

ABM Offers Opportunity for Professional Growth

Appointment-based models are typically most effective when all pharmacy team members participate.


Jenni Thomas, PharmD

Latest:

Pharmacists Can Make a Difference in Antibiotic Stewardship at Discharge

Pharmacist-led discharge stewardship initiatives have shown promising results.



Kara Melmed, MD

Latest:

AAN 2025: Intracerebral Hemorrhage Treatment Requires Proactive Approach, Pharmacist Involvement

Kara Melmed, MD, emphasizes the critical importance of rapid, team-based intervention for intracerebral hemorrhage (ICH) patients, with pharmacists playing a key role in blood pressure management.


Stefanie P. Ferreri, PharmD, BCACP, FAPhA

Latest:

Incorporation of Medication Synchronization in Community Pharmacy Workflow Enhances Delivery of Patient Care Services

The biggest advantage of med sync for a community pharmacy is the proactive selection of a date to have all the patient’s chronic medications filled simultaneously.


Corey J. Medler, PharmD, MPh, BCIDP

Latest:

Overcoming Metallo-β-Lactamases: A Review of Cefepime-Taniborbactam

Cefepime-taniborbactam shows promise against resistant infections, but more studies are needed.


Kaylee Nichols, PharmD Candidate 2022

Latest:

Overview of Nurtec ODT for Prevention of Episodic Migraine

Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.


Thomas Swalla

Latest:

AI’s Shot in the Arm of Science and the Concerns We Need to Address

Stakeholders need to convene honest, actionable discussions about the challenges and the safeguards needed to address appropriate use of artificial intelligence in health care.


Jennifer Park, PharmD Candidate

Latest:

Understand Tofersen, the First FDA-Approved Drug Targeted to Slow Disease Progression in SOD1-Mutated ALS

Pharmacists play a key role in optimizing drug therapy according to the most updated guidelines, educating patients or prescribers, and monitoring therapeutic outcomes.


Luke Halpern, Assistant Editor

Latest:

Dalpiciclib Plus Endocrine Therapy Prolonged Invasive Disease-Free Survival in HR+/HER2– Breast Cancer

Dalpiciclib combined with endocrine therapy significantly enhances progression-free survival in HR+/HER2– breast cancer, as shown in the DAWNA-A trial.


Jason Mordino, PharmD, BCCCP

Latest:

Getting in the Mindset to Become a Successful Preceptor: How to Precept Responsibly

Students should prepare to be preceptors early in their pharmacy school careers.


Douglas Braun, PharmD, RPh, CPH, CSP

Latest:

From Abemaciclib to Trastuzumab Deruxtecan: Highlights From the 2024 San Antonio Breast Cancer Symposium

Experts presented results that may transform treatment and clinical practice strategies.